Ethylene

Ethylene

SCHEMBL6995582

C=C.CCOC(C)OCC.COc1cccc2c1C(=O)CN(CCN1CCN(c3ccc(F)cc3)CC1)S2(=O)=O

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
ATM Q13315 1/20 0.40
DRD4 P21917 3/20 0.39
DRD2 P14416 3/20 0.39
HTR1A P08908 2/20 0.39
HTR7 P34969 2/20 0.39
ADRA2A P08913 1/20 0.39
ADRA2B P18089 1/20 0.39
ADRA2C P18825 1/20 0.39
HTR2A P28223 1/20 0.39
HTR2C P28335 1/20 0.39
SLC6A4 P31645 1/20 0.39
ADRA1A P35348 1/20 0.39
HRH1 P35367 1/20 0.39
ADRA1B P35368 1/20 0.39
DRD3 P35462 1/20 0.39
OPRK1 P41145 1/20 0.39
HTR5A P47898 1/20 0.39
HTR6 P50406 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethylene SCHEMBL6997038 0.95 HTR7 (0.42) MEN1KMT2AATMDRD4DRD2
Ethylene SCHEMBL6995181 0.95 DRD2 (0.43) MEN1KMT2AATMDRD4DRD2
Ethylene SCHEMBL6992834 0.89 DRD2 (0.39) DRD4DRD2HTR1AHTR7ADRA2A
Ethylene SCHEMBL6995689 0.89 HTR7 (0.41) DRD4DRD2HTR1AHTR7HTR2A
Ethylene SCHEMBL6991302 0.86 TDP1 (0.42) DRD4DRD2HTR1AHTR7ADRA2A
Ethylene SCHEMBL6996554 0.85 DRD2 (0.43) DRD4DRD2HTR1AHTR7ADRA2A
SCHEMBL7107493 0.85 DRD2 (0.51) MEN1KMT2AATMDRD4DRD2
Ethylene SCHEMBL6994102 0.85 HTR1A (0.48) DRD4DRD2HTR1AHTR7ADRA2A
Ethylene SCHEMBL6997843 0.84 DRD2 (0.44) MEN1KMT2ADRD4DRD2HTR1A
Ethylene SCHEMBL6998179 0.82 DRD2 (0.47) DRD4DRD2HTR1AHTR7ADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6664251-B2 Serotonin receptor antagonist; treating cardiovascular disorder DAIICHI SUNTORY PHARMA CO., LTD. (JP) 2003-12-16 US disclosed
US-20030078256-A1 Benzothiazine derivative SUNTORY LIMITED (JP) 2003-04-24 US disclosed
EP-0749967-B1 Substituted benzothiazine derivative SUNTORY LTD (JP) 2003-01-22 EP disclosed
US-6316442-B1 TREATMENT OF HEART DISEASE AND CEREBROVASCULAR DISTURBANCES SUNTORY LIMITED (JP) 2001-11-13 US disclosed
US-6001827-A Benzothiazine derivative SUNTORY LIMITED (JP) 1999-12-14 US disclosed
EP-0749967-A1 Substituted benzothiazine derivative SUNTORY LIMITED (JP) 1996-12-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030078256-A1 Benzothiazine derivative TPH2, ADRB2, TPH1 MEN1 2318/4885KMT2A 1497/4885ATM 3451/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.